Cite
Han C, Wang SM, Bahk WM, et al. Corrigendum: A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial. Clin Psychopharmacol Neurosci. 2020;18(4):641doi: 10.9758/cpn.2020.18.4.641.
Han, C., Wang, S. M., Bahk, W. M., Lee, S. J., Patkar, A. A., Masand, P. S., Mandelli, L., Pae, C. U., & Serretti, A. (2020). Corrigendum: A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 18(4), 641. https://doi.org/10.9758/cpn.2020.18.4.641
Han, Changsu, et al. "Corrigendum: A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial." Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology vol. 18,4 (2020): 641. doi: https://doi.org/10.9758/cpn.2020.18.4.641
Han C, Wang SM, Bahk WM, Lee SJ, Patkar AA, Masand PS, Mandelli L, Pae CU, Serretti A. Corrigendum: A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial. Clin Psychopharmacol Neurosci. 2020 Nov 30;18(4):641. doi: 10.9758/cpn.2020.18.4.641. PMID: 33124599; PMCID: PMC7609217.
Copy
Download .nbib